Background: The present study is an analysis of appropriateness of antibiotics use for patients in whom infectious agent was detected. Data from patients in orthopedics and traumatology department of 2 hospitals in the same district were evaluated according to rational antibiotic drug use guidelines and culture antibiogram results. Methods: Data of patients diagnosed with infection between January 1, 2014 and December 31, 2015 in orthopedics and traumatology department of 2 different hospitals were analyzed. Patients diagnosed with malignancy or who were discharged from other departments were excluded. A standard form was used to collect demographic data, culture antibiogram results, details of infectious agent, source of culture material, posology of antibiotic used, duration and appropriateness of use, and length of hospital stay. Costs were estimated based on number of units used and price per unit according to 2014 Ministry of Health price list. Mean price of antibiotics used per patient was calculated and descriptive analyses were also completed. Results: It was determined that appropriate antibiotics for detected infectious agent were not always selected. Though there were effective, less expensive antibiotics that could have been used according to antibiogram results, more expensive antibiotics were often chosen, resulting in greater total cost. Conclusion: Multidisciplinary approach in patient care and use of evidence-based guidelines should be increased. Teams should be formed and led by infectious disease and pharmacology specialists. New strategies should be developed immediately in health economics and new pharmacoeconomic models should be initiated in orthopedics and traumatology departments.
Introduction
In recent years, it has been reported that orthopedic implants have been used more frequently in treatment of bone fractures and arthritis, and accordingly, a gradual increase in incidence of infection and antibiotic use has also been indicated. [1, 2] In parallel with the increase in antibiotic use, it has been acknowledged that other drugs and pharmacological products employed in treatment of infection incur excessive burden on total expenditures, social welfare institutions, and national economies. [3, 4] In addition, literature findings have demonstrated that appropriate treatment procedure for infectious diseases is important because of the serious threat to public health of antibacterial resistance, as well as its economic burden. [5] The fundamental target of healthcare providers, especially in treatment of infectious diseases, is to be able to administer proper, cost-effective, and individualized treatment within optimal time with minimal side effects. [6] Therefore, rational drug use continues to be an important agenda item. Within this framework, international guidelines were prepared, and work groups and committees were established that are still actively performing their duties at local or national level. Many studies have confirmed widespread and irrational use of antibiotics. [7, 8] The present study is an analysis of antibiotic use and treatment costs for patients hospitalized and followedup on for diagnosis of infection in the orthopedics and traumatology department of 2 different neighboring public hospitals using laboratory, clinical, and current guidelines. The secondary purpose of the study was to raise awareness about rational antibiotic use among orthopedic surgeons and other healthcare professionals.
Patients and Methods

Approval of Ethics Committee
Approval of the ethics committee was obtained to conduct this multi-centered retrospective investigation.
Selection of Cases
The study is an analysis of records from between January 1, 2014 and December 31, 2015 of the orthopedics and traumatology department of 2 neighboring secondary care public hospitals with approximately 400 beds each in Tekirdağ province. Hospital records regarding patient care and antibiotics used in 2812 cases treated in 30 beds in Hospital 1 (Group 1) and 35 beds in Hospital 2 (Group 2), were examined.
Infectious agent detected in patients, length of hospital stay, antibiotics used, drug costs, and share of hospital budget were calculated and compared using electronic hospital information system and material sources management system. Study population consisted of a total of 3068 patients (Hospital 1: n=1769; Hospital 2: n=1299). Patients who were released on first day of hospitalization (Hospital 1: n=2; Hospital 2: n=6), those with malignancy (Hospital 1: n=9; Hospital 2: n=17), treatment refractory cases (Hospital 1: n=11; Hospital 2: n=9), patients referred to another service (Hospital 1: n=43; Hospital 2: n=37) or to another hospital (Hospital 1: n=61; Hospital 2: n=47); patients who declined treatment (Hospital 1: n=9; Hospital 2: n=5), and those who couldn't meet the study criteria (Hospital 1: n=135; Hospital 2: n=121) were excluded. A total of 2812 patients were included in the study.
Demographic information, vital and laboratory findings (fever, white blood cell count [WBC] , erythrocyte sedimentation rate [ESR], C-reactive protein [CRP] , and if available, results of antibiotic susceptibility tests), data related to clinical diagnosis, antibiotic use (dose, duration, route of administration, information about prophylactic antibiotics), and approval of specialist in infectious diseases (according to guidelines of rational drug use and infection control committees) were recorded on pre-prepared standard information forms. In addition, conformity assessments were conducted after investigation of suitability of antibiotics used in light of drug usage information.
Evaluation of Costs
Costs of drugs and pharmacological products were calculated by multiplying unit price by number of units used. Unit prices were determined based on price lists specified by Turkish Ministry of Finance and Turkish Ministry of Health Medicines and Medical Devices Agency. [9] Costs of nursing services and drug preparation costs were not taken into account.
Following calculation of direct cost of antibiotics, an additional pharmacoeconomic analysis was done based on selection of the least expensive antibiotic with equivalent benefit according to different methods of medical treatment and diagnosis. [10] 
Statistical Analysis
Data were calculated based on Turkish lira. Descriptive analyses were performed using Microsoft Office Excel program and presented as mean±SD and percent change (frequency, percentage).
Results
A total of 2812 cases were analyzed from Hospital 1 (n=1634, 58.1%) and Hospital 2 (n=1178, 41.9%). Hospital 1 cases consisted of 622 male (43.6%) and 556 female patients with overall mean age of 52.97±20.47 years. Mean age of patients in Hospital 2 was 49.03±20.12 years; there were (52.8%) male.
Mean hospital stay of inpatients in Hospital 1 was 5.71±6.03 days. Shortest hospital stay was 1 day, a patient with fractured distal end of tibia, and longest stay was 101 days, a patient with open wound on calf. In Hospital 2, mean hospital stay was 8.92±7.90 days. The shortest stay was 1 day, also for patient with fractured distal end of tibia, while the longest hospital stay was 45 days, a patient who was diagnosed as osteomyelitis.
Antibiotic susceptibility tests were performed on patients in Hospital 1 who developed infection or who were hospitalized with diagnosis of infection based on culture antibiogram results of sputum (n=1), urine (n=10), and wound (n=119) samples. Sputum cultures revealed growth of upper respiratory tract flora. In urine cultures of 8 patients, no bacterial growth was detected, while in 1 patient, mixed bacterial growth was observed that was evaluated as contamination. No bacterial growth was detected in 77 wound site cultures, while 7 were evaluated as contamination with normal skin flora. In Hospital 2, significant bacterial growth was observed in 24 wound and 8 urine cultures ( Table 1) .
Cost of drugs and pharmacological products and total hospital expenditures for department of orthopedics and traumatology were calculated for the year of the study ( Table 2 ). Ratio of antibiotic drug costs to total cost of drugs and pharmacological products was estimated at 37.98% in Hospital 1, and 33.43% in Hospital 2. Costs of antibiotics used in both hospitals are shown in Figure 1 . In Hospitals 1 and 2, prophylactic cephazolin use for each patient was 6.25 g and 7.66 g, respectively.
Results of antibiotic susceptibility tests were analyzed, and instead of choosing a low-cost antibiotic sensitive to microorganism based on antimicrobial treatment guidelines, [11] [12] [13] preference for expensive antibiotic group with broad spectrum was determined. For instance, in Hospital 1, for 5 patients, instead of using lower cost antibiotics with higher sensitivity such as vancomycin, teicoplanin, erythromycin, or gentamycin, antibiotics with active ingredient of linezulid that have higher treatment cost were chosen without relevant justification (n=5). In treatment of infections caused by microorganisms sensitive to piperacillintazobactam, cefepime, cefaperazone-sulbactam, gentamicin, and amikacin, meropenem group of antibiotics with higher treatment cost were chosen in 17 cases. In another 6 cases sensitive to less expensive ciprofloxacin, preference for levofloxacin was determined.
In Hospitals 1 and 2, inappropriate antibiotic was preferred instead of pharmaceutical alternative antibiotic with lower cost in 80% (n=28), and 71.88% (n=23) of cases, respectively.
Discussion
Irrational antibiotic use directly affects public health due to development of resistant bacteria and increased morbidity and mortality rates, as well as indirectly by preventing allocation of necessary financial resources to health problems of top priority due to increase in health expenses. [14] [15] [16] There have been reports from many European countries, including Turkey, of adverse outcomes concerning inappropriate antibiotic use and widespread antibiotic resistance. [17] In a study where European countries were compared, it was emphasized that in France inappropriate use of antibiotics was a great public health problem, and antibiotics costs should be urgently reduced. [18] [19] [20] In a study published by the World Health Organization (WHO) Regional Office for Europe, it was reported that in many countries, including Turkey, broad spectrum antibiotics were being used with increasing frequency, and that excessive use of third-generation cephalosporins was indicated in Turkey. [18] Preoperatively, for surgical prophylaxis, use of cephazolin at dose of 1 g has been recommended. [21] When patient data were evaluated, it was observed that active ingredient used for prophylaxis was the same employed in the literature. However, we detected extended period of prophylactic use of a certain dose of the active ingredient. In Hospitals 1 and 2, prophylactic cephazolin dose for each individual patient were 6.25 g and 7.66 g, respectively.
Akgün et al. investigated risk factors related to development of surgical site infection in patients without systemic disease who had undergone elective orthopedic and neurosurgical surgeries. They reported that surgical site infection had developed in 13 patients, and that culture material obtained from 7 patients whose culture antibiogram tests revealed growth of Pseudomonas aeruginosa in 1, and Enterococcus faecalis in another patient. [22] In the present study, culture medias of patients in Hospital 1, growth of Acinetobacter baumanii (n=3), Pseudomonas aeruginosa (n=3), and extended spectrum pathogens grown in culture media were resistant to antibiotics.
In the same study, a survey was administered to 114 orthopedic surgeons who were members of the American Orthopedic Foot, and Ankle Society regarding use of prophylactic oral antibiotics. More than half (63%) of the surgeons included in the study reported that they were using 500 mg cephalexin at 6 hourintervals for 5-7 days for preoperative prophylaxis. They underlined the necessity of using a suitable costeffective oral antibiotic that also overcomes resistance mechanism of pathogens. [23] In the present study, it was observed that oral antibiotherapy was not preferred for pre-and postoperative periods in either hospital, which does not comply with literature data.
In an investigation by Karahocagil et al., authors indicated higher rates of antibiotic use with an incidence of 67.2% in departments of orthopedics and traumatology. [24] Azap et al. reported that they didn't detect inappropriate use of antibiotherapy in patients in whom initiation of treatment was based on available microbiological data. [25] Based on the results of the assessment of present study data, incidence rates of antibiotic use were 37.98% and 33.43%, respectively, in Hospitals 1 and 2. In addition, inappropriate antibiotic use in terms of drug expenditure was observed in 80% (n=28) of patients in Hospital 1, and 71.88% (n=23) of patients in Hospital 2.
Xu et al. reported that treatment plans for routine prophylactic antibiotic use in orthopedic surgery were not definitive, and indicated that as a result of extremely widespread and inappropriate antibiotic use, proliferation of antibiotic resistant pathogenic microorganisms resulting in increase in healthcare expenditures has been promoted. [26] In another study, despite the limited amount of highquality evidence the authors presented, they indicated that adoption of clinical guidelines might improve clinical applications by decreasing variation and create conditions required for the multi-center studies necessary for systematic reviews. [27] Yüksek et al. conducted a study at a tertiary care research, and application hospital to research infectious agents isolated from inpatients and their antibiotic resistance patterns, and reported that infections are serious problems. They emphasized that knowledge about microorganisms grown in the culture media of the patients hospitalized in services would aid in the selection of appropriate empiric treatment and protection of the patients from contamination with resistant microorganisms. [28] The current study investigated one of the important items related to drug expenditures, namely cost of antibiotics, and it is one of limited number of investigations that emphasize variations in antibiotic use and the related costs. Although the study has strong points, the fact that data were retrieved retrospectively from hospital archives is a limitation.
In this study it was indicated that antibiotics were most frequently used in Hospital 1, (13485 pieces, total cost TL 32,821.47), and according to the results of antibiotic susceptibility tests, 80% of them incurred unnecessary financial burden. In Hospital 2, 13979 pieces of antibiotics were used during the period studied at a cost of TL 21,567.39; 71.88% of the antibiotics used were not appropriate based on antibiotic susceptibility test results.
According to the results found in this study, the participation of specialists in orthopedics and traumatology on the committees of infection control and rational drug use, as well as clinical pharmacologist and hospital pharmacist, is important in terms of raising awareness about rational antibiotic use and drug costs. Further studies should be conducted on this subject. Comprehensive scientific studies should be conducted in healthcare institutions, including departments of orthopedics and traumatology of tertiary care hospitals, and data obtained should be shared.
